The challenge of using experimental infectivity data in risk assessment for Ebola virus: why ecology may be important.
Analysis of published data shows that experimental passaging of Zaire ebolavirus (EBOV) in guinea pigs changes the risk of infection per plaque-forming unit (PFU), increasing infectivity to some species while decreasing infectivity to others. Thus, a PFU of monkey-adapted EBOV is 10(7) -fold more lethal to mice than a PFU adapted to guinea pigs. The first conclusion is that the infectivity of EBOV to humans may depend on the identity of the donor species itself and, on the basis of limited epidemiological data, the question is raised as to whether bat-adapted EBOV is less infectious to humans than nonhuman primate (NHP)-adapted EBOV. Wildlife species such as bats, duikers and NHPs are naturally infected by EBOV through different species giving rise to EBOV with different wildlife species-passage histories (heritages). Based on the ecology of these wildlife species, three broad 'types' of EBOV-infected bushmeat are postulated reflecting differences in the number of passages within a given species, and hence the degree of adaptation of the EBOV present. The second conclusion is that the prior species-transmission chain may affect the infectivity to humans per PFU for EBOV from individuals of the same species. This is supported by the finding that the related Marburg marburgvirus requires ten passages in mice to fully adapt. It is even possible that the evolutionary trajectory of EBOV could vary in individuals of the same species giving rise to variants which are more or less virulent to humans and that the probability of a given trajectory is related to the heritage. Overall the ecology of the donor species (e.g. dog or bushmeat species) at the level of the individual animal itself may determine the risk of infection per PFU to humans reflecting the heritage of the virus and may contribute to the sporadic nature of EBOV outbreaks.
Department of Epidemiological Sciences, Animal and Plant Health Agency (APHA), Weybridge, UK.
P
P
Gale
Department of Epidemiological Sciences, Animal and Plant Health Agency (APHA), Weybridge, UK.
R R L
RR
Simons
Department of Epidemiological Sciences, Animal and Plant Health Agency (APHA), Weybridge, UK.
V
V
Horigan
Department of Epidemiological Sciences, Animal and Plant Health Agency (APHA), Weybridge, UK.
E L
EL
Snary
Wildlife Zoonoses and Vector-borne Diseases Research Group, Animal and Plant Health Agency (APHA), Weybridge, UK.|Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, UK.|NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, Liverpool, UK.
A R
AR
Fooks
Department of Virology, Animal and Plant Health Agency (APHA), Weybridge, UK.
T W
TW
Drew
D000818:Animals; D000835:Animals, Wild / Q000821:virology; D004195:Disease Models, Animal; D004285:Dogs; D029043:Ebolavirus / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology*; D004463:Ecology; D006168:Guinea Pigs; D019142:Hemorrhagic Fever, Ebola / Q000821:virology*; D006801:Humans; D051379:Mice; D018570:Risk Assessment; D014774:Virulence
Ebola virus; dose-response; ecology; passage; wildlife